Chroma Therapeutics

United Kingdom
Saint Stephen, England, United Kingdom
+441235829120 ★

Company profile

Chroma Therapeutics company profile

Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. Chroma is the first company to systematically assemble intellectual property in chromatin biology and has established a strong network of academic collaborators. Chroma aims to build substantial shareholder value through the creation of a broad and innovative product pipeline aimed at the treatment of high-prevalence cancers and inflammatory disorders.

Business identity

Contact email
[email protected]
Phone number
+441235829120
Operating status
Active
Company type
For Profit
Employee range
00051-00100 employees
Revenue range
$10K+
Founded
2000-01-01

Headquarters

Headquarters
Saint Stephen, England, United Kingdom
Postal code
OX14 4RY
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
5
Total equity funding
$97.4M
Last funding
Debt Financing / $15M / 2010-05-05
Last equity funding
Series D / $24.5M
Investors
9
Lead investors
2
Founders
2
Articles
5

Founders and investors

Founders

Paul WorkmanTony Kouzarides

Lead investors

Hercules CapitalPhase4 Ventures

Investors

AbingworthEssex Woodlands Healthcare PartnersGilde HealthcareHercules CapitalWellcome Trust

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.